Small Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization
Small Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance
Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.
There are 20 small cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap between $250M and $2B — worth a combined $20.1B.
The largest by market cap are BioCryst Pharmaceuticals (BCRX) at $1.92B, Eton Pharmaceutcials (ETON) at $1.84B and Trulieve Cannabis (TRLV) at $1.76B.
Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.
- Combined market cap: $20.1B across 20 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: BioCryst Pharmaceuticals (BCRX), $1.92B market cap.
- Most net new fund positions in Q3 2026: Eton Pharmaceutcials (ETON), +49 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.